COVID-19 Drug Discovery Assays
Reaction Biology understands the increasingly urgent need to address the COVID-19 situation with clinically approved therapeutic drugs. To support the drug discovery community in the challenge to identify efficacious COVID-19 drugs, we have developed specific assays to block SARS-CoV-2 virus entry and replication.
Our COVID-19 therapeutic drug testing service is available for pharmaceutical companies and medical researchers worldwide. Get in touch with the business development manager assigned to your country today.
Our SARS-CoV-2 drug screening services include: